Analysis calls for transparency in FDA reporting of trials

(EDITOR'S NOTE: A version of this article appeared in the October 2026 issue of The Brown University Psychopharmacology Update , also published by Wiley.)

Authors

Publication Details

Journal
Mental Health Weekly
Published
2026-09-11
DOI
https://doi.org/10.1002/mhw.35004
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis calls for transparency in FDA reporting of trials

Valerie A. Canady
Mental Health Weekly
Treatment of Major Depression
article

Analysis calls for transparency in FDA reporting of trials

Valerie A. Canady
article en

Abstract

(EDITOR'S NOTE: A version of this article appeared in the October 2026 issue of The Brown University Psychopharmacology Update , also published by Wiley.)

Mental Health WeeklyVol. 36(35)
Openalex Percentile: Top 12%
Treatment of Major Depression
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.